Skip to main content

Tissue Typing Policy

  • Chapter
  • 43 Accesses

Part of the book series: New Clinical Applications Nephrology ((NCNG,volume 9))

Abstract

What is tissue typing and how might it influence policy in relation to kidney transplantation? To answer these questions, some relationships between tissue matching, graft survival and function will be considered. Present policy and whether it could be improved will then be discussed.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Counce, S., Smith, P., Barth, R. and Snell, G. D. (1956) Strong and weak histocompatibility gene differences in mice and their role in the rejection of homografts of tumours and skin. Ann. Surg., 144, 198–204

    Article  PubMed  Google Scholar 

  2. Breimer, M. W., Brynger, H., Le Pendu, J., Oriol, R., Rydberg, L., Samuelsson, B. E. and Vinas, J. (1987). Blood group ABO-incompatible kidney transplantation biochemical and immunochemical studies of blood group A glycolipid antigens in human kidney and characterization of the antibody response (antigen specificity and antibody class) in 0 recipients receiving A2 grafts. Transplant. Proc., 19, 226–230

    PubMed  CAS  Google Scholar 

  3. Rydberg, L., Breimer, M. E., Samuelsson, B. E. and Brynger, H. (1987). Blood group ABO-incompatible (A2 to 0) kidney transplantation in human subjects: a clinical, serologic, and biochemical aproach. Transplant. Proc., 19, 4528–4537

    PubMed  CAS  Google Scholar 

  4. Welsh, K. I., van Dam, M., Koffman, C. G., Bewick, M. E., Rudge, C. J., Tuabe, D. H. and Clark, A.G.B. (1987). Transplantation of blood group A2 kidneys into 0 or B recipients: the effect of pretransplant anti-A titers on graft survival Transplant. Proc., 19, 4565–4567

    PubMed  CAS  Google Scholar 

  5. Shapira, Z., Yussim, A., Shmueli, D. and Nakache, R. (1987). Experience with blood group A2 renal grafts in ABO-incompatible recipients. Transplant Proc., 19, 4562–4564

    PubMed  CAS  Google Scholar 

  6. Cook, D. J., Graver, B. and Terasaki, P. I. (1987). ABO incompatibility in cadaver donor kidney allografts. Transplant Proc., 19, 4549–4552

    PubMed  CAS  Google Scholar 

  7. Ting, A. and Morris, P.J. (1983). Successful transplantation with a positive T and B cell crossmatch due to autoreactive antibodies. Tissue Antigens, 21, 219–226

    Article  PubMed  CAS  Google Scholar 

  8. Falk, J. A., Cardella, C. J., Halloran, P., Robinette, M., Arbus, G. and Bear, R. (1985). Transplantation can be performed with positive (noncurrent) crossmatch Transplant. Proc., 17, 1530–1532

    Google Scholar 

  9. Kerman, R. H., Flechner, S. M., Van Buren, C. T., Lorber, M. I. and Kahan, B. D. (1985). Successful transplantation of cyclosporine treated allograft recipients with serologically positive historical, but negative preoperative, donor crossmatches. Transplantation, 40, 615–619

    Article  PubMed  CAS  Google Scholar 

  10. Opelz, G. (1985). Correlation of HLA matching with kidney graft survival in patients with or without cyclosporine treatment. Transplantation, 40, 240–243

    Article  PubMed  CAS  Google Scholar 

  11. Terasaki, P. I., Toyotome, A., Mickey, M. R., Cicciarelli, J., Iwaki, Y., Cecka, M. and Tiwari, J. (1985). Patient, graft, and functional survival rates: an overview. In Terasali, P. I. (ed.) Clinical Kidney Transplants, Chapt. 1, pp. 1–26. (California: UCLA Tissue Typing Laboratory)

    Google Scholar 

  12. Salvatierra, O., Vicenti, F., Amend, W., Carovoy, M., Iwaki, Y., Terasaki, P., Potter, D., Duca, R., Hopper, S., Slemmer, T. and Feduska, N. (1983). Four-year experience with donor-specific blood transfusion. Transplant. Proc., 15, 924–931

    Google Scholar 

  13. Festenstein, H., Doyle, P. and Holmes, J. (1986). Long-term follow-up in London Transplant Group recipients of cadaver renal allografts. N. Engl. J. Med., 314, 7–13

    Article  PubMed  CAS  Google Scholar 

  14. Cecka, J. M. (1986). The changing role of HLA matching. In Terasaki, P. I. (ed.) Clinical Transplants, Chapt. 16, pp. 141–155. (California: UCLA Tissue Typing Laboratory)

    Google Scholar 

  15. Persijn, G. G., de Lange, P., D’Amaro, J., Cohen, B., Liebelt, P., Hendriks, G. F. J. and van Rood, J. J. (1986). Eurotransplant Part II. The cyclosporine era 1981–1985. In Terasaki, P.I. (ed.) Clinical Transplants, Chapt. 13, pp.99–107. (California: UCLA Tissue Typing Laboratory)

    Google Scholar 

  16. Chapman, J. R., Taylor, C., Ting, A. and Morris, P.J. (1986). Hyperacute rejection of a renal allograft in the presence of anti-CW5 antibody. Transplantation, 42, No. 1, 91–92

    Article  PubMed  CAS  Google Scholar 

  17. European Multicentre Trial Group (1983). Cyclosporin in cadaveric renal transplantation: one-year follow-up of a multicentre trial. Lancet, 2, 986–989

    Article  Google Scholar 

  18. Madsen, M., Graugaard, B., Fjeldborg, O., Hansen, H. E., Posborg, V. and Kissmeyer-Nielsen (1985). The impact of HLA-DR antigen matching in cyclo-sporine-treated recipients of cadaveric renal allografts. A single-center analysis. Transplant. Proc., 17, No. 6, 2202–2204

    Google Scholar 

  19. Joysey, V. C., Thiru, S. and Evans, D. B. (1985). Effect of HLA-DR compatibility on kidney transplants treated with cyclosporine A. Transplant. Proc., 17, No. 6, 2187–2192

    Google Scholar 

  20. Gilks, W. R., Bradley, B. A., Gore, S. M. and Klouda, P. T. (1987). Substantial benefits of tissue matching in renal transplantation. Transplantation, 43, No. 5, 669–673

    Article  PubMed  CAS  Google Scholar 

  21. Opelz, G. (1988). Importance of HLA antigen splits for kidney transplant matching. Lancet, 2, 61–64

    Article  PubMed  CAS  Google Scholar 

  22. Opelz, G. (1987). Kidney transplantation in sensitized patients. Transplant. Proc., 19, No. 5, 3737–3741

    PubMed  CAS  Google Scholar 

  23. Iwaki, Y. and Terasaki, P.I. (1986). Sensitization effect. In Terasaki, P.I. (ed.) Clinical Transplants, Chapt. 25, pp. 257–265. (California: UCLA Tissue Typing Laboratory)

    Google Scholar 

  24. Sanfilippo, F., Goeken, G., Niblack, G., Scornik, J. and Vaughn, W. K. (1987). The impact of HLA-A, B match of primary renal allografts subsequent to transplant failure. Transplant. Proc., 19, 669–671

    PubMed  CAS  Google Scholar 

  25. Hendriks, G. F. J., Schreuder, G. M. Th., Claas, F. H. J., D’Amaro, J., Persijn, G. G., Cohen, B. and van Rood, J.J. (1983). HLA-DRw6 and renal allograft rejection. Br. Med. J., 286, 85–87

    Article  CAS  Google Scholar 

  26. Hendriks, C. F. J., D’Amaro, J., Pensijn, G. G., Schreuder, G. M. T., Lansbergen, Q., Cohen, B. and van Rood, J. J. (1983). Excellent outcome after transplantation of renal allografts from HLA-DRw6 positive donors even in HLA-DR mismatches. Lancet, 2, 187–189

    Article  PubMed  CAS  Google Scholar 

  27. Vereerstraeten, P., Andrien, M., Dupont, E., De Pauw, L., Kinnaert, P. and Toussaint, C. (1987). Influence of donor and recipient DRw6 status on outcome of cadaver kidney transplantation. Transplant. Proc., 19, No. 1, 708–710

    PubMed  CAS  Google Scholar 

  28. Cook, D. J. (1986). HLA-DR associated immune responsiveness. In Terasaki, P. I. (ed.) Clinical Transplants, Chapt. 24, pp. 247–256. (California: UCLA Tissue Typing Laboratory)

    Google Scholar 

  29. Smiley, M. L., Wlodaver, C. G., Grossman, R.A., Barker, C. F., Perloff, L. J., Tustin, N. B., Starr, S. E., Plotkin, S. A. and Friedman, H. M. (1985). The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation. Transplantation, 40, No. 2, 157–161

    Article  PubMed  CAS  Google Scholar 

  30. Grundy, J. E., Lui, S. F., Super, M., Berry, N. J., Sweny, P., Fernando, O. N., Moorhead, J. and Griffiths, P. D. (1988). Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet, 2, 132–135

    Article  PubMed  CAS  Google Scholar 

  31. Opelz, G. (1988). Allocation of cadaver kidneys for transplantation. Transplant. Proc., 20, No. 1, Suppl. 1, 1028–1032

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers

About this chapter

Cite this chapter

Joysey, V.C. (1989). Tissue Typing Policy. In: Catto, G.R.D. (eds) Transplantation. New Clinical Applications Nephrology, vol 9. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0855-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-0855-0_3

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6872-7

  • Online ISBN: 978-94-009-0855-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics